Ümit Can ERİM

Dr. Ümit Can ERİM


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
MAMUHAMMET DAVUT ARPA
MUHAMMET DAVUT ARPA
ISİkBal Merve Seçen
İkBal Merve Seçen
ÜEÜmit Can ERİM
Ümit Can ERİM
AHAyşegül Hoş
Ayşegül Hoş
Neslihan Üstündağ OkurNeslihan Üstündağ Okur
Neslihan Üstündağ Okur
In this study, hydrogels containing azelaic acid were developed using chitosan or HPMC (1-7%) for local treatment of acne vulgaris. Physicochemical properties such as viscosity, pH and mechanical properties were evaluated. In vitro release and ex vivo permeability studies were performed using Franz diffusion cell system. The pH of the hydrogels were highly compatible with the skin pH and varied between 4.38–5.84. The cumulative release percentages of the hydrogels at the end of 6 hours were 65-78%, whereas the marketed product yielded 50% drug release. According to the ex vivo permeability results, azelaic acid accumulated in the skin were found to be 9.38 ± 0.65% (marketed cream), 19.53 ± 1.06% (K3), 10.96 ± 1.91% (H6). The antiacne studies with Cutibacterium acnes revealed that K3 (29.45 ± 0.95) and H6 (32.35 ± 0.15) had higher inhibition zones compared to the marketed cream (24.50 ± 0.90). Additionally, the gels were found to be highly stable as a result of the stability studies for 6 months. Among the hydrogels that were prepared based on experimental findings, K3 (3% Chitosan) and H6 (6% HPMC) represented elevated in vitro release profile, higher permeability and increased antiacne activity. The findings of this research suggest that the developed hydrogels might be an alternative to the marketed product. Graphical Abstract


14 August 2024 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
IOIlyas Ozcicek
Ilyas Ozcicek
GBGulsena Baydas
Gulsena Baydas
ÜEÜmit Can ERİM
Ümit Can ERİM
UUUnsal Veli Ustundag
Unsal Veli Ustundag

28 September 2025 in Gels
Verified
Journal Article
Open access
PDF file
MAMUHAMMET DAVUT ARPA
MUHAMMET DAVUT ARPA
ÜEÜmit Can ERİM
Ümit Can ERİM
ESEbrar Elif Kesmen Salik
Ebrar Elif Kesmen Salik
SBSevde Nur Biltekin
Sevde Nur Biltekin
IEIsmail Erol
Ismail Erol
Chitosan is a promising biopolymer for drug delivery due to its biocompatibility, biodegradability, and low toxicity. However, its limited dispersibility in water restricts applications, which can be improved through organic acid salts. This study examined how acetic, lactic, glutamic, and citric acids influence the physicochemical, rheological, swelling, bioadhesive, stability, and cytotoxicity properties of chitosan hydrogels. Gels were prepared using varying chitosan-to-acid molar ratios (1:1; 1:1.2 for citrate) and characterized by NMR, FTIR, TGA, and XRD. Despite identical chitosan concentrations (2%, 3%, 3.5%), gels displayed distinct viscosity, swelling, and adhesion profiles depending on the acid. Lactate gels exhibited the most favorable overall performance, combining high viscosity (1555–6665 mPa·s), structural stability, and strong bioadhesion. Citrate gels showed the lowest viscosity (825–3550 mPa·s), cell viability, and stability but the highest bioadhesiveness, likely due to multivalent ionic interactions. Short-term stability tests revealed that low pH accelerated chitosan degradation, leading to viscosity loss up to ~90–95% within 30 days, particularly in citrate hydrogels. Cytotoxicity tests confirmed high biocompatibility, with all formulations maintaining cell viability above 80%. Overall, the findings highlight that organic acid selection is a critical determinant of chitosan gel behavior, offering guidance for tailoring safe, stable, and bioadhesive drug delivery systems.

14 August 2024 in International Journal of Environmental Science and Technology
Verified
Journal Article
Closed access
PDF file
ÜEÜmit Can ERİM
Ümit Can ERİM
MGM. Gülfen
M. Gülfen
AAA. O. Aydın
A. O. Aydın

22 February 2026 in Biomedical Chromatography
Verified
Journal Article
Closed access
TITuğba Iduğ
Tuğba Iduğ
HGHikmet Gülben Güç
Hikmet Gülben Güç
IÇIşık Çelik
Işık Çelik
ÜEÜmit Can ERİM
Ümit Can ERİM
Hüseyin Onur TUNCAYHüseyin Onur TUNCAY
Hüseyin Onur TUNCAY